|
|
420 Lexington Avenue, Suite 212
New York, NY 10170 USA
phone:(212) 687-1050
fax: (212) 687-1051
|
|
| Symbol |
LCAR |
| Exchange |
.OB |
| Founded |
3 |
| Employees |
|
|
|
| www.lescarden.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Natural biologic therapies for the chronic wound care, dermatology and osteoarthritis markets. |
|
| Management |
| William Luther, Pres, Chief Exec. Officer, Director |
| |
|
|
|
|
|
|
|
| Keywords |
| woundwound, woundcare |
|
|
|
| Description |
|
Lescarden, Inc. is a biotechnology company developing natural biologic therapies for the chronic wound care, dermatology and osteoarthritis markets.
Lescarden's research team, led for many years by one of its founders, Dr. John Prudden, is responsible for the studies conducted with bovine cartilage. These efforts brought the Lescarden team to the successful development of Catrix, a product that is recognized for its therapeutically diverse applications in chronic wound healing, dermatology, inflammatory joint disease, and metastatic renal cell cancer. |
|
| Products / Services |
Catrix Wound Dressing, a highly refined powder made from tracheal cartilage, is approved by the Food and Drug Administration for use in the management of a wide range of wounds including chronic skin ulcers and burns.
Catrix Skin Care line of topical products are used by dermatologists and plastic surgeons to relieve irritation and expedite healing following dermatologic procedures.
Biocar Laboratories Ltd., a division of Lescarden, Inc., produces pharmaceutical grade nutritional supplements including Bio-Cartilage, 100% pure bovine cartilage and Poly-NAG, a polymeric source of glucosamine made from crustacean shells. Poly-NAG has recently been awarded a U.S. patent for use as an anti-arthritic.
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
